Catalyst Wire Dossier Catalyst Wire Dossier

Volociximab (M200)

volociximab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Volociximab (M200), covering 2013-01-18 to 2013-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) [Phase 1, Phase 2]

See pricing